期刊文献+

羟考酮与舒芬太尼在自主呼吸下胸腔镜手术中的作用比较

The comparison of oxycodone and sufentanial administrated in non-intubation thoracoscopic surgery
原文传递
导出
摘要 目的比较羟考酮与舒芬太尼在保留自主呼吸胸腔镜肺大泡切除术中的效果。方法选择2018年1月至2019年12月,根据实验样本量计算,择期行胸腔镜肺大泡切除术的患者50例,其中男性28例,女性22例;年龄18~35岁,平均(26.3±4.7)岁。采用随机数字表法随机分成羟考酮组(O组)和舒芬太尼组(S组),每组25例。两组患者均在胸段椎旁阻滞后静脉诱导置入喉罩保留自主呼吸。麻醉诱导:予右美托咪定1μg/kg泵注,丙泊酚4μg/mL靶控输注(TCI)O组予0.2 mg/kg羟考酮静脉推注,S组予0.2μg/kg舒芬太尼静脉推注。术中维持:丙泊酚2μg/mL TCI靶控输注,吸入1%七氟醚。记录入室时(T_(0))、喉罩放置后15 min、30 min(T_(1)、T_(2))、术后30 min(T_(3))二氧化碳分压(PaCO_(2))、氧分压(PaO_(2))和PH值,计算两组患者术中时间加权的自主呼吸潮气量(TWA-VT)、呼吸频率(TWA-f)、氧饱和度(TWA-SpO_(2))和呼气末二氧化碳分压(TWA-P_(ET)CO_(2));记录患者术中呛咳、术后24 h内恶心呕吐等不良反应情况。结果(1)与S组比较,O组患者在T_(1)、T_(2)时PH和PaO_(2)值升高,PaCO_(2)降低(P<0.05)。(2)与S组比较,O组患者术中的TWA-V_(T)和TWA-f升高,TWA-P_(ET)CO_(2)下降(P<0.05)。(3)O组患者术中及术后不良反应发生率低于S组患者(P<0.05)。结论在保留自主呼吸胸腔镜肺大泡切除术中,与舒芬太尼比较,羟考酮能够优化围术期呼吸管理,且术中及术后不良反应发生率低。 Objective To compare the efficacies of oxycodone and sufentanil administrated in non-intubation thoracoscopic surgery.Methods A total of 50 patients including 28 males and 22 females undergoing non-intubation thoracoscopic surgery were randomly divided into two groups with 25 patients in each group,the age ranged from 18 to 35 years old,and the average age was(26.3±4.7)years old.After performing the thoracic paravertebral nerve block(T4、T5),the patients were induced with dexmedetomidine(1μg/kg)and propofol(4μg/mL TCI),and then 0.2 mg/kg oxycodone and 0.2μg/kg sufentanil were administrated respectively in group O and S.The anesthesia was maintained with propofol and sevoflurane and all patients were kept spontaneous breathing with the aid of LMA mask.During the process of surgery,the results of blood gas analysis were recorded respectively at the moment of in operating room(T0),15min,30min after Laryngeal mask ventilation(T_(1)、T_(2)),30min after surgery(T_(3)).The time-weighted average VT,f,SpO_(2) and P_(ET)CO_(2) were calculated.In addition,the intraoperative cough and Nausea and vomiting 24h after surgery were recorded.Results(1)Compared with that of the patients in group S,the PH,PaO_(2) in group O were risen at T_(1) and T_(2),while the PaCO_(2) were reduced(P<0.05).(2)Compared with that of the patients in group S,the TWA-VT and TWA-f in group O were increased,while the TWA-P_(ET)CO_(2) were decreased(P<0.05).(3)The intraoperative and postoperative incidence of adverse reactions in group O were less than that of patients in group S(P<0.05).Conclusions For the patients undergoing non-intubation thoracoscopic surgery,oxycodone can optimize intraoperative respiratory management and ameliorate the intraoperative and postoperative incidence of adverse reactions.
作者 胡义凤 汪陈豪 吴周全 Hu Yifeng;Wang Chenhao;Wu Zhouquan(Department of Anesthesiology,Nanjing Medical University Affiliated Wuxi Second Hospital Wuxi,Wuxi 214002,China;Nanjing Medical University Affiliated Changzhou NO.2 people’hospital Changzhou,Changzhou 213003,China)
出处 《中华卫生应急电子杂志》 2021年第6期349-352,共4页 Chinese Journal of Hygiene Rescue(Electronic Edition)
基金 江苏省青年卫生人才项目(QNRC2016273)。
关键词 羟考酮 舒芬太尼 自主呼吸 胸腔镜手术 Oxycodone Sufentanil Spontaneous breathing Thoracoscopic surgery
  • 相关文献

参考文献3

二级参考文献24

  • 1邢燕,王保国,孙立,时文株,安建雄,范婷.瑞芬太尼在神经外科手术麻醉中靶浓度的研究[J].首都医科大学学报,2006,27(5):581-585. 被引量:6
  • 2Pasternak GW.Molecular biology of opioid analgesia.J Pain Symptom Manage,2005,29(5 Suppl):S2-9. 被引量:1
  • 3Andreassen TN,Klepstad P,Davies A,et al.Is oxycodone efficacy reflected in serum concentrations? A multicenter,cross sectional study in 456 adult cancer patients.J Pain Symptom Manage,2012,43(4):694-705. 被引量:1
  • 4Staahl C,Dimcevski G,Andersen SD,et al.Different effect of opioids in patients with chronic pancrdatitis:an experimental pain study.Scand J Ganstroenterol,2007,42(3):383-390. 被引量:1
  • 5Davis MP,Varga J,Dickerson D,et al.Normal-release and controlled release oxycodone:pharmacokinetics,pharmacodynamics,and controversy.Support Care Cancer,2003,11(2):84-92. 被引量:1
  • 6King SJ,Reid C,Forbes K,et al.A systematic review of oxycodone in the management of cancer pain.Palliat Med,2011,25(5):454-470. 被引量:1
  • 7King S1,Forbes K,Hanks GW.A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment:a European Palliative Care Research Collaborative opioid guidelines project.Palliat Med,2011,25(5):525-552. 被引量:1
  • 8Lazzari M,Sabato AF,Caldarulo C,et al.Effectiveness and tolerability of low dose oral oxycodone/naloxone added to anticonvulsant therapy for noncancer neuropathic pain:an observational analysis.Curr Med Res Opin,2014,30(4):555-564. 被引量:1
  • 9McNicol ED,Midbari A,Eisenberg E.Opioids for neuropathic pain.Cochrane Database Syst Rev,2013,8:CD006146. 被引量:1
  • 10Lancaster T,McQuay H.Review:tricyclic antidepressants,capsaicin,gabapentin,and oxycodone are effective for postherpetic neuralgia.ACP J Club,2002,137(2):52. 被引量:1

共引文献480

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部